Lecture 2.2 Flashcards
(51 cards)
Target discovery is comprised of 3 steps:
- provision of disease models
- target identification
- target validation
What are the 2 approaches to target discovery?
- ‘molecular’ approach
- ‘systems’ approach
What is the ‘molecular approach’ to target discovery?
uses techniques such as genomics, proteomics, genetic association and reverse genetics
What is the ‘systems approach’ to target discovery?
uses clinical and in vivo studies to identify potential targets.
Briefly explain how target validation is done?
modulation of gene expression and/or protein function in both cell and animal models is used to confirm the role of the target
What are some techniques for target identification?
- radioligand binding
- DNA microarray
- in silico methods
- correlative technologies (proteomics,
genomics, genetic association) - phenotype-driven target identification
–> forward genetics and reverse genetics
Briefly explain the technique of ‘radioligand binding’
Bind the potential receptors with radioligands so that the targets can be picked out from a
pool of other receptors
What are the steps involved with radioligand binding?
- ligands with high specificity for particular
targets are labeled with radioisotopes - tissue (containing target of interest) mixed
with radioligands - bound receptors separated, cloned and their
nucleotide sequence decoded
Briefly explain the purpose of ‘DNA microarray’
By measuring the expression profile, identify the target genes that cause disease
What are the steps involved with DNA microarray?
- array of genes (ssDNA) printed on solid
support of membrane - mRNA from healthy + diseased used to
generate cDNAs - cDNA labeled with fluorescent tags
- incubated with microarray support
- genes in samples pair up with
complementary counterparts - fluorescence indicates level of expression
–> disease-related genes revealed
Briefly explain an in silico method for target identification.
ESTs of interest compared with those in database for known protein structures
–> further aided by database on 3D protein structures, AA sequence in sample
What are Expressed Sequence Tags (ESTs)?
Short nucleotide sequences of cDNA that code for the expression of particular proteins
What are some correlative technologies used for target identification?
techniques to measure differential expression of mRNA or protein
for RNA (genomics) –> PCR
for protein (proteomics) –> gel electrophoresis + mass spec
How are genetic association studies used to identify targets?
Researchers compare the frequency of genetic variants (such as SNP) between individuals with a particular trait or disease (cases) and individuals without the trait or disease (controls).
What is ‘forward genetics’ in phenotype-driven target identification?
random modulation of the phenotype using in vitro biological and chemical library screen or in vivo chemical mutagenesis and the subsequent identification of the gene (phenotype to gene)
What is ‘reverse genetics’ in phenotype-driven target identification?
gene manipulation and examination of the phenotype (target gene is known beforehand)
–>determine their functional roles in disease processes and assess their potential as therapeutic targets
Genomics includes developing and utilizing tools for the prediction and detection of:
- genes
- sequence similarity
- motif/domain similarity
- gene expression variants
(measurement of mRNA levels through
microarray analysis)
What are the limitations of genomics?
mRNA expression levels do not reliably predict protein expression levels
Why can’t we use mRNA expression levels to predict protein expression levels?
- different half-lives in cells
- PTMs after translation
- cannot predict localisation of proteins
- cannot provide info on protein interactions
How to overcome the limitation of genomics studies?
study the function, structure and interactions of proteins themselves at a system-wide scale
What is functional genomics?
systematic analysis of gene activity in healthy versus diseased organisms/ organs/ tissues/ cells.
According to functional genomics, disease mechanisms can be broadly classified into:
- defects in distinct genes - genetic disorder (down
syndrome) - infection by bacteria, fungi, viruses (AIDS, HIV-
infection, COVID-19) - immune-autoimmune diseases (SLE)
- multicausal disease (functional dyspepsia)
- trauma and acute disease based on injury or organ
failure
What environmental factos may raise the risk of developing a particular disease?
diet, toxic exposure, trauma, stress
Functional genomics explores gene function through the analysis of:
- Regulatory pathways
- biochemical pathways
- protein-protein interactions
- effects of gene knockouts, gene up-regulation, gain-of-
function - results of functional complementation of knockouts